SonoScape Medical Corp. (SHE:300633)
China
· Delayed Price · Currency is CNY 25.72
-0.13 (-0.50%)
Mar 10, 2026, 11:15 AM CST
SonoScape Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,111 | 12,656 | 20,370 | 23,460 | 12,833 | 10,443 | Upgrade
|
| Market Cap Growth | -17.65% | -37.87% | -13.17% | 82.80% | 22.89% | 7.69% | Upgrade
|
| Enterprise Value | 9,995 | 11,212 | 18,761 | 22,088 | 12,399 | 10,186 | Upgrade
|
| Last Close Price | 25.85 | 29.30 | 46.76 | 54.03 | 31.36 | 25.40 | Upgrade
|
| PE Ratio | 166.82 | 88.88 | 44.82 | 63.44 | 51.91 | - | Upgrade
|
| Forward PE | 41.70 | 25.87 | 34.58 | 57.53 | 50.58 | 78.06 | Upgrade
|
| PS Ratio | 5.35 | 6.29 | 9.61 | 13.31 | 8.88 | 8.98 | Upgrade
|
| PB Ratio | 3.56 | 4.07 | 6.48 | 8.56 | 5.45 | 7.76 | Upgrade
|
| P/TBV Ratio | 3.88 | 4.46 | 7.24 | 9.73 | 6.32 | 10.64 | Upgrade
|
| P/FCF Ratio | - | 126.82 | 65.19 | 82.92 | 85.13 | 90.15 | Upgrade
|
| P/OCF Ratio | - | 41.27 | 41.62 | 49.57 | 42.36 | 38.52 | Upgrade
|
| EV/Sales Ratio | 4.82 | 5.57 | 8.85 | 12.53 | 8.58 | 8.76 | Upgrade
|
| EV/EBITDA Ratio | 127.97 | 68.42 | 36.95 | 61.94 | 50.04 | 59.48 | Upgrade
|
| EV/EBIT Ratio | - | 111.05 | 40.99 | 68.81 | 57.35 | 71.54 | Upgrade
|
| EV/FCF Ratio | -43.60 | 112.35 | 60.04 | 78.07 | 82.26 | 87.93 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.11 | 0.02 | 0.08 | 0.05 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 3.92 | 1.94 | 0.14 | 0.58 | 0.41 | 2.61 | Upgrade
|
| Debt / FCF Ratio | - | 3.56 | 0.23 | 0.77 | 0.74 | 3.86 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.53 | -0.56 | -0.56 | -0.55 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -18.89 | -10.10 | -3.45 | -4.31 | -5.26 | -2.64 | Upgrade
|
| Net Debt / FCF Ratio | 4.87 | -16.58 | -5.61 | -5.43 | -8.65 | -3.91 | Upgrade
|
| Asset Turnover | 0.50 | 0.50 | 0.58 | 0.54 | 0.55 | 0.50 | Upgrade
|
| Inventory Turnover | 1.03 | 1.33 | 1.38 | 1.31 | 1.42 | 1.37 | Upgrade
|
| Quick Ratio | 1.91 | 2.08 | 3.55 | 2.64 | 3.00 | 1.40 | Upgrade
|
| Current Ratio | 3.04 | 2.75 | 4.62 | 3.36 | 3.84 | 1.80 | Upgrade
|
| Return on Equity (ROE) | 2.15% | 4.55% | 15.44% | 14.52% | 13.36% | -3.36% | Upgrade
|
| Return on Assets (ROA) | -0.20% | 1.56% | 7.82% | 6.11% | 5.13% | 3.81% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.69% | 7.09% | 33.84% | 27.59% | 21.64% | 14.99% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.40% | 3.10% | 14.30% | 11.50% | 8.80% | 10.00% | Upgrade
|
| Earnings Yield | 0.60% | 1.13% | 2.23% | 1.58% | 1.93% | -0.44% | Upgrade
|
| FCF Yield | -2.06% | 0.79% | 1.53% | 1.21% | 1.18% | 1.11% | Upgrade
|
| Dividend Yield | 0.39% | 0.34% | 0.68% | 0.33% | 0.40% | - | Upgrade
|
| Payout Ratio | 72.38% | 101.36% | 18.20% | 15.62% | 2.24% | - | Upgrade
|
| Buyback Yield / Dilution | 0.68% | 0.30% | -0.65% | -7.83% | -3.44% | 5.08% | Upgrade
|
| Total Shareholder Return | 1.06% | 0.64% | 0.04% | -7.50% | -3.04% | 5.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.